title: [Platelet antiaggregants].
abstract: Antiplatelet agents are indicated in the prophylactic treatment of certain thromboses, and in particular those due to a complication of atherosclerosis. Acetylsalicylic acid is the best-known, the most commonly used and, probably, the currently most effective agent. The dosage remains controversial; yet, a mean dose of 300 mg daily appears to be recommended nowadays. Ticlopidine and, to a lesser extent, dipyridamole can also be used for this treatment. However numerous contra-indications, such as haemorragic diathesis, surgery and gastric ulcers tend to limit their use. As regards the combination of antiplatelet agents, clinical studies do not show superior efficacy as compared with acetylsalicyclic acid alone.
authors.affiliation: Service de Biochimie médicale Cliniques Universitaires St-Luc, Bruxelles, Belgique.
authors.forename: L
authors.initials: L
authors.lastname: Verstraeten
authors.forename: P
authors.initials: P
authors.lastname: François
mesh_terms: D000818:Animals; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use
chemical_list: D010975:Platelet Aggregation Inhibitors
vernacular_title: Les antiagrégants plaquettaires.